Study of Adacel® Vaccine Administered to Persons 10 Years of Age

ClinicalTrials.gov ID: NCT01311557

Public ClinicalTrials.gov record NCT01311557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age

Study identification

NCT ID: NCT01311557
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Sanofi; Industry
Enrollment: 1,302 participants

Conditions and interventions

Conditions

Interventions

Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed Biological

Biological

Eligibility (public fields only)

Age range: 10 Years to 11 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 28, 2011
Primary completion: Oct 31, 2011
Completion: Dec 31, 2011
Last update posted: Apr 7, 2016

2011 – 2012

United States locations

U.S. sites: 34
U.S. states: 23
U.S. cities: 34

Facility	City	State	ZIP	Site status
Not listed	Chandler	Arizona	85224	—
Not listed	Jonesboro	Arkansas	72401	—
Not listed	Little Rock	Arkansas	72205	—
Not listed	Sacramento	California	95816	—
Not listed	Longmont	Colorado	80501	—
Not listed	Norwich	Connecticut	06360	—
Not listed	Miami Beach	Florida	33141	—
Not listed	Marietta	Georgia	30062	—
Not listed	Woodstock	Georgia	30189	—
Not listed	Bardstown	Kentucky	40040	—
Not listed	Crestview Hills	Kentucky	41017	—
Not listed	Louisville	Kentucky	40202	—
Not listed	Madisonville	Kentucky	42431	—
Not listed	Haughton	Louisiana	71037	—
Not listed	Metairie	Louisiana	70006	—
Not listed	Woburn	Massachusetts	01801	—
Not listed	Plymouth	Minnesota	55441	—
Not listed	Rochester	New York	14609	—
Not listed	Cleveland	Ohio	44121	—
Not listed	Pittsburgh	Pennsylvania	15241	—
Not listed	Warwick	Rhode Island	02886	—
Not listed	Barnwell	South Carolina	29812	—
Not listed	Rapid City	South Dakota	57701	—
Not listed	Kingsport	Tennessee	37660	—
Not listed	Austin	Texas	78705	—
Not listed	Fort Worth	Texas	76135	—
Not listed	San Antonio	Texas	78205	—
Not listed	Orem	Utah	84057	—
Not listed	Salt Lake City	Utah	84124	—
Not listed	South Jordan	Utah	84095	—
Not listed	Midlothian	Virginia	23113	—
Not listed	Vienna	Virginia	22180	—
Not listed	Spokane	Washington	99202	—
Not listed	Marshfield	Wisconsin	54449	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01311557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 7, 2016 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01311557 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →